SUE TSUDA M.D. NPI 1275532715

NPI Details

Sue Tsuda, M.D. is a medical oncology internal medicine in Conway, AR with 41 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Sue Tsuda, M.D. NPI is 1275532715. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Graduation Year:1984

The provider's business location address is:

350 SALEM RD STE 4
CONWAY, AR
ZIP 72034-166
Phone: (501) 327-2995
Fax: (501) 327-2331

The NPI 1275532715 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, sargramostim (gm-csf), 50 mcg (HCPCS:J2820)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood creatinine level (HCPCS:82565)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Unclassified drugs (HCPCS:J3490)
• Blood test, clotting time (HCPCS:85610)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ct scan of chest without contrast (HCPCS:71250)
• Drawing of blood for a medical problem (HCPCS:99195)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Iron binding capacity (HCPCS:83550)
• Chemical receptor analysis (HCPCS:84238)

The enumeration date for this NPI number is 7/18/2005 and was last updated on 5/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.